INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 369 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.08 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,051,464 | +53.9% | 33,355 | +99.1% | 0.00% | – |
| Q2 2023 | $683,193 | +11.2% | 16,753 | +1.6% | 0.00% | – |
| Q1 2023 | $614,484 | -95.7% | 16,487 | -96.0% | 0.00% | -100.0% |
| Q4 2022 | $14,328,000 | -41.1% | 410,822 | -5.6% | 0.01% | -44.4% |
| Q3 2022 | $24,340,000 | +13.5% | 434,976 | +5.0% | 0.01% | +28.6% |
| Q2 2022 | $21,436,000 | -31.7% | 414,157 | -4.2% | 0.01% | -22.2% |
| Q1 2022 | $31,407,000 | -39.3% | 432,160 | -1.2% | 0.01% | -35.7% |
| Q4 2021 | $51,728,000 | -11.7% | 437,490 | +0.2% | 0.01% | -26.3% |
| Q3 2021 | $58,592,000 | +66.4% | 436,777 | +100.9% | 0.02% | +72.7% |
| Q2 2021 | $35,209,000 | +2776.6% | 217,456 | +1385.1% | 0.01% | – |
| Q1 2021 | $1,224,000 | +292.3% | 14,643 | +79.6% | 0.00% | – |
| Q4 2020 | $312,000 | +108.0% | 8,153 | -27.7% | 0.00% | – |
| Q3 2019 | $150,000 | -73.7% | 11,281 | -67.6% | 0.00% | – |
| Q2 2019 | $570,000 | +182.2% | 34,851 | +195.5% | 0.00% | – |
| Q1 2019 | $202,000 | -92.5% | 11,794 | -87.5% | 0.00% | -100.0% |
| Q3 2018 | $2,702,000 | -2.0% | 94,381 | -9.3% | 0.00% | 0.0% |
| Q2 2018 | $2,758,000 | – | 104,021 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,216,340 | $62,958,000 | 7.04% |
| Discovery Value Fund | 584,483 | $30,253,000 | 6.33% |
| MPM BioImpact LLC | 299,409 | $15,497,000 | 4.30% |
| ARK Investment Management | 9,514,580 | $439,003,000 | 2.60% |
| Elmwood Wealth Management, Inc. | 67,899 | $3,514,000 | 2.00% |
| Nikko Asset Management Americas, Inc. | 2,781,136 | $141,143,000 | 1.74% |
| Avidity Partners Management LP | 1,125,194 | $58,240,000 | 1.34% |
| Merlin Capital, Inc | 12,174 | $630,000 | 1.26% |
| Atlas Venture Associates IX, LLC | 10,000 | $518,000 | 1.18% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $5,768,000 | 1.16% |